Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China · Delayed Price · Currency is CNY 13.77
-0.65 (-4.51%)
Aug 21, 2026, 3:04 PM CST
SHE:300233 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,824 | 2,737 | 3,373 | 3,538 | 3,506 | 3,138 |
Revenue Growth | -5.08% | -18.87% | -4.66% | 0.93% | 11.70% | 5.96% |
Gross Profit Gross Profit Growth | 944.79 | 924.48 | 1,304 | 1,465 | 1,574 | 1,597 |
Operating Income Operating Income Growth | 176.26 | 86.21 | 265.27 | 219.96 | 373.34 | 223.97 |
Net Income Net Income Growth | 139.68 | 44.19 | 196.78 | 174.71 | 273.37 | 107.98 |
Earnings Per Share EPS Growth | 0.39 | 0.12 | 0.52 | 0.45 | 0.71 | 0.28 |
EPS Growth | 36.32% | -76.92% | 15.56% | -36.62% | 153.57% | - |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Others Others Growth | 30.57 |
Formulation Division Formulation Division Growth | 942 |
Intermediates Division Intermediates Division Growth | 1,304 |
Specialty APIs Specialty APIs Growth | 519.85 |
Offset of Business Segment Offset of Business Segment Growth | -59.23 |
Total Total Growth | 2,737 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 963.33 | 896.03 | 917.91 | 1,025 | 859.13 | 981.18 |
Total Debt Total Debt Growth | 334.96 | 379.44 | 515.56 | 554.12 | 650.91 | 652.62 |
Net Cash (Debt) Net Cash Growth | 628.38 | 516.59 | 402.35 | 470.54 | 208.22 | 328.55 |
Net Cash Growth | 64.42% | 28.39% | -14.49% | 125.98% | -36.62% | -50.66% |
Net Cash Per Share Net Cash Per Share Growth | 1.75 | 1.40 | 1.06 | 1.21 | 0.54 | 0.85 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 409.05 | 319.64 | 296.59 | 664.08 | 255.63 | 437.19 |
Capital Expenditures CapEx Growth | -106.86 | -100.88 | -142.61 | -342.9 | -373.67 | -376.14 |
Free Cash Flow Free Cash Flow Growth | 302.19 | 218.76 | 153.97 | 321.18 | -118.04 | 61.04 |
Free Cash Flow Growth | 139.00% | 42.08% | -52.06% | - | - | -77.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 33.46% | 33.78% | 38.65% | 41.40% | 44.89% | 50.87% |
Operating Margin | 6.24% | 3.15% | 7.86% | 6.22% | 10.65% | 7.14% |
Pretax Margin | 6.79% | 2.85% | 7.96% | 6.37% | 9.87% | 6.26% |
Profit Margin | 4.95% | 1.61% | 5.83% | 4.94% | 7.80% | 3.44% |
FCF Margin | 10.70% | 7.99% | 4.56% | 9.08% | -3.37% | 1.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | 0.250 | 0.200 | 0.150 | 0.198 |
Dividend Per Share Growth | -37.50% | 0% | 25.00% | 33.33% | -24.31% | -1.82% |
Dividend Yield | 1.82% | 1.80% | 2.16% | 1.27% | 0.70% | 0.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 35.36 | 120.10 | 23.13 | 36.27 | 31.98 | 103.41 |
Forward PE | - | 24.24 | 24.24 | 24.24 | 24.24 | 24.24 |
P/FCF Ratio | 17.29 | 24.26 | 29.56 | 19.73 | - | 182.94 |
PS Ratio | 1.85 | 1.94 | 1.35 | 1.79 | 2.49 | 3.56 |